Pharmacists in Kansas City, Missouri


733 Pharmacists found in Kansas City
female pharmacist

Vanessa Joy Mamie, PHARMD



2301 Holmes St, Kansas City, MO 64108
816-404-1000    

female pharmacist

Victoria Louise Dillon-bader


Pharmacist
1224 Jefferson St, Kansas City, MO 64105
417-499-6111    

female pharmacist

Victoria Blazek, PHARMD



2401 Gillham Rd, Kansas City, MO 64108
816-302-3724    



female pharmacist

Dr. Victoria Benjamin, PHARM D


Pharmacist
9430 Blue Ridge Blvd, Kansas City, MO 64138
816-765-5279     816-765-5879

female pharmacist

Miss Vivian Thuc-anh Nguyen, PHARM.D.


Pharmacist
4801 E Linwood Blvd, Kansas City, MO 64128
816-861-4700    

male pharmacist

Dr. Weston Erbert, PHARMD


Pharmacist
241 E Linwood Blvd, Kansas City, MO 64111
816-216-0002     816-216-0009

female pharmacist

Mrs. Whitney Faye Hessel, PHARM.D.


Pharmacist
2301 Holmes St, Kansas City, MO 64108
816-404-4293    

male pharmacist

Dr. William Michael Burke, PHARMD


Pharmacist
4630 Troost Ave, Kansas City, MO 64110
816-931-8337     816-931-4980

male pharmacist

William Lipira, R.PH.


Pharmacist
5979 N Saline Ave, Kansas City, MO 64151
816-646-6562    

male pharmacist

Dr. William D Smith Jr., PHARM.D.


Pharmacist
3501 Gladstone Blvd, Kansas City, MO 64123
417-667-1761    

male pharmacist

William Stanley, R.PH.


Pharmacist
2330 E Meyer Blvd Ste T103, Kansas City, MO 64132
816-822-7700     816-822-7761

female pharmacist

Mrs. Yume Hoang Nguyen, PHARM D


Pharmacist
4149 N Oak Trfy, Kansas City, MO 64116
816-454-5541    

female pharmacist

Yunhsuan Hoover


Pharmacist
7900 Lees Summit Rd, Kansas City, MO 64139
816-404-9036    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.